Skip to main content
Intermediate Technical IVT

vigabatrin

Pronunciation: vy-GAB-ah-trin

An antiepileptic drug that is first-line treatment for infantile spasms, particularly in tuberous sclerosis complex.

Full Definition

Vigabatrin is a gamma-aminobutyric acid (GABA) transaminase inhibitor that increases brain GABA levels and serves as a crucial antiepileptic drug in pediatric neurology. It is particularly effective as first-line treatment for infantile epileptic spasms associated with tuberous sclerosis complex, where it may be preferred over ACTH. Vigabatrin is also used for focal seizures refractory to other medications. The drug requires careful monitoring due to the risk of irreversible bilateral concentric visual field defects, necessitating regular ophthalmological assessments. Despite this significant side effect, vigabatrin remains essential in treating specific epilepsy syndromes where benefits outweigh risks.

Usage

Usage note: Not to be confused with gabapentin or other GABA-related drugs. Requires specialized visual monitoring.

In Context

  • "Vigabatrin was chosen as first-line therapy given the patient's tuberous sclerosis complex." — Treatment plan
  • "Regular visual field monitoring is mandatory for all patients receiving vigabatrin." — Clinical protocol

Also known as

VGB

Don't confuse with

gabapentin pregabalin tiagabine

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON